Thesis (Ph. D.)--Ohio State University, 2006. / Title from first page of PDF file. Includes bibliographical references (p. 255-300).

Norovirus (NoV) and Sapovirus (SaV) are major causes of outbreak gastroenteritis worldwide. NoV and SaV are highly infectious, have multiple transmission routes and have a short incubation period, thereby facilitating rapid intercontinental spread of new variants. Consequently, a treatment would be advantageous for controlling them. However, currently little is known about the replication cycle and evolution of human NoV or SaV as neither are culturable. NoV and SaV are RNA viruses of the Caliciviridae family and have great genetic diversity which is thought to facilitate irnmune evasion. Consequently variants of NoV GI1.4 arose in 1996, 2002, 2004 and in 2006 and resulted in pandemics. Therefore, in this study, the role of the two main mechanisms associated with generating viral diversity; recombination, and point mutation were investigated for NoV and SaV. Physiological and kinetic properties of three NoV RdRps (genotypes, Gll.b, Gll.4, Gll.7) and two SaV RdRps (genogroups GI, GII) were also investigated. RNA recombination is a significant driving force in viral evolution. Increased awareness of recombination within the Calicivirus genus Norovirus (NoV) has led to a rise in the identification of NoV recombinants and they are now reported at high frequency. Despite this no classification system exists for recombinant NoVs As a result, there is duplication in reporting novel recombinants and the precise number of novel NoV recombinant types is unknown. Therefore, in order to elucidate thero!e of recombination in NoV evolution, 121 NoV nucleotide sequences, compiled from the GenBank database and published literature, were analysed for recombination events. NoV recombinants and their recombination breakpoint were identified using three methods: phylogenetic analysis, Simplot analysis and the Maximum Chi-Squared method. In total 19 unique NoV recombinant types were identified in circulation across the globe and they had a common recombination point near the ORF1/2 overlap. Recombination at the ORF1/0RF2 overlap could have important implications in NoV evolution as it enables a virus to swap its antigenic determinates (capsid) and thereby avoid immune clearance in an analogous manner to antigenic shift in influenza virus. This study also examined the role of NoV and SaV replication in generating viral diversity by comparing the physiological, kinetic and biochemical properties of five genotypically distinct RdRps from two different genera of the Caliciviridae. Genetically diverse HuCV RdRps were expressed in Escherichia coli and characterised in an in vitro assay designed for this study. The results indicated that despite high sequence variation between the five enzymes (between 6% and 71% amino acid difference) they shared similar physiological properties. Though there was some variation in their template usage and kinetic properties. SaV was able to perform primer dependent replication on homopolymeric A RNA whereas the NoV RdRps were not. Additionally, NoV RdRps had a higher incorporation rate and were more kinetically efficient than the two SaV RdRps. The incorporation fidelity of the five enzymes was similar (between 2.2x10-5 to 8.9x10-4 ), although interestingly the most prevalent strain, Gll.4, had the lowest fidelity of the caliciviruses. Therefore, suggesting that RdRp fidelity has an important role in NoV evolution. Overall, this study illustrated that NoV and SaV generate genetic diversity in a similar fashion to other RNA viruses, that is, a delicate combination of recombination, point mutation and replication efficiency. Understanding the mechanisms involved in viral replication and genomic diversity of the calicivirus RdRps is essential if a successful control strategy for the human caliciviruses is going to be developed.

Thesis (PhD) - Faculty of Life and Social Sciences, Swinburne University of Technology, 2007. / Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, Faculty of Life and Social Sciences, Swinburne University of Technology - 2007. Typescript. "September 2007". Includes bibliographical references (p. 173-204).

Diarrhoeal disease is considered the second most common cause of morbidity and fourth most common cause of mortality, worldwide. Low-income countries such as those in Africa and Asia bear the greatest burden of gastroenteritis. Diarrhoeal disease affects individuals of all ages, however, children <5 years of age, the immunocompromised and the elderly population ≥65 years of age are most severely affected. The elderly population, particularly immunocompromised patients residing in long-term care facilities represent high-risk groups for gastroenteritis and surveillance of these individuals in South Africa is under-represented. It has been observed that an individual’s fucosyltransferase 2 (FUT2) secretor status has been associated with different degrees of infection by rotaviruses and noroviruses. A total of 1 012 stool specimens from elderly patients were collected over an 18-month surveillance period, of which 340 specimens met the inclusion criteria and were tested. Virus screening was performed using a lyophilised real-time multiplex RT-PCR/PCR screening iv assay testing for norovirus GI and GII, rotavirus, human adenovirus, human astrovirus and sapovirus. Careful analysis of the real-time (RT)-PCR amplification plots and export data identified 50 viruses in 40 patient specimens. Seven norovirus GI/GII dual-infections were observed and three co-infections were identified, each with an astrovirus accompanying infection by a rotavirus, sapovirus and human adenovirus. FUT2 genotyping was performed to acquire the secretor status for all the rotavirus- and norovirus-positive individuals. The real-time TaqMan® SNP Genotyping Assay was inconsistent in amplifying the SNP in the FUT2 gene from stool-extracted DNA of elderly patients, and therefore an alternative, conventional genotyping PCR approach was performed. This approach was successful in acquiring the secretor status of 14/21 patient specimens. A total of 10 homozygous secretors, three heterozygous secretors and one homozygous non-secretor were identified. Virus-positive specimens identified in this study were genotyped and subjected to phylogenetic analysis. Overall, 14 norovirus- GI, 12 norovirus- GII, 10 sapovirus-, six human adenovirus-, six human astrovirus- and two rotavirus-positives were identified. From the 14 norovirus GI positives, three polymerase regions and two capsid regions were successfully genotyped. The polymerase strains all belonged to genotype GI.P1 and the capsid sequences were all GI.1 genotypes. Only one virus was successfully dual-genotyped as GI.1[P1]. For norovirus GII, a total of nine polymerase and nine capsid strains were genotyped successfully. All the polymerase sequences belonged to the GII.P31 genotype and eight capsid sequences identified as GII.4 Sydney 2012 strains, with a single GII.6 genotype identified. Three of the six adenovirus positives were genotyped, of which one strain grouped into species C and two strains grouped into species D, and shared a clade with a type 17 reference strain. Human astrovirus dual-genotyping was successful for three strains, which identified as type 2 for both the serine protease and capsid types. A single rotavirus strain was genotyped for VP4 and VP7 and identified as G9P[6]. Only two sapovirus-positives were successfully genotyped as GI.2 and GIV.1, respectively. This study highlights the epidemiological importance of clinical surveillance in the geriatric population, acting as a cornerstone for future studies in South Africa. / Dissertation (MSc (Medical Virology))--University of Pretoria, 2019. / The dissertation is under embargo until September 2022. / National Research Foundation / Poliomyelitis Research Foundation / Medical Virology / MSc (Medical Virology) / Restricted

O mamastrovirus 5 (MAstV5) é classificado no gênero Mamastrovirus da família Astroviridae, sendo associado com surtos agudos de gastroenterite transitória em filhotes de cães ao redor do mundo. O objetivo desta dissertação foi detectar e analisar a variabilidade genética dos MAstV5 circulantes em cães no Brasil. Para isto, amostras de suabe retal foram coletadas de 269 cães de diferentes regiões do Brasil no período de 2008-2014, dos quais 26,39% foram positivos para MAstV5 através de RT-PCR convencional e de RT-Hemi-nested PCR, amplificando porção conservada do gene do capsídeo e do gene da polimerase, respectivamente. Quatro destas cepas tiveram seu genoma parcialmente sequenciado, caracterizado e analisado filogeneticamente. A caracterização dessas amostras revelou uma notável heterogeneidade genética entre as cepas de MAstV5. A baixa identidade entre as sequências do gene do capsídeo (<85%) indicaria uma possível nova classificação entre a espécie MAstV5 em dois genótipos. Conclue-se que o MAstV5 ocorre em cães no Brasil e as cepas circulantes possuem uma grande diversidade genética. / The Mamastrovirus 5 (MAstV5) is classified in the genus Mamastrovirus of the Astroviridae family, being associated with acute episodes of transient gastroenteritis in puppies around the world. The aim of this work was to detect and analyze the genetic variability of circulating MAstV5 in dogs in Brazil. For this, rectal swab samples were collected from 269 dogs from different regions of Brazil in the 2008-2014 period, of which 26.39% were positive for MAstV5 by conventional RT-PCR and RT-Hemi-nested PCR, amplifying conserved portion of the capsid gene and polymerase gene, respectively. Four of these strains had its genome sequenced partially characterized and analyzed phylogenetically. The characterization of these samples revealed a remarkable genetic heterogeneity among strains of MAstV5. The low identity between the sequences of capsid gene (<85%) indicate a possible new classification between the two genotypes MAstV5 species. We conclude that the MAstV5 occurs in dogs in Brazil and circulating strains have a high genetic diversity.

O mamastrovirus 5 (MAstV5) é classificado no gênero Mamastrovirus da família Astroviridae, sendo associado com surtos agudos de gastroenterite transitória em filhotes de cães ao redor do mundo. O objetivo desta dissertação foi detectar e analisar a variabilidade genética dos MAstV5 circulantes em cães no Brasil. Para isto, amostras de suabe retal foram coletadas de 269 cães de diferentes regiões do Brasil no período de 2008-2014, dos quais 26,39% foram positivos para MAstV5 através de RT-PCR convencional e de RT-Hemi-nested PCR, amplificando porção conservada do gene do capsídeo e do gene da polimerase, respectivamente. Quatro destas cepas tiveram seu genoma parcialmente sequenciado, caracterizado e analisado filogeneticamente. A caracterização dessas amostras revelou uma notável heterogeneidade genética entre as cepas de MAstV5. A baixa identidade entre as sequências do gene do capsídeo (<85%) indicaria uma possível nova classificação entre a espécie MAstV5 em dois genótipos. Conclue-se que o MAstV5 ocorre em cães no Brasil e as cepas circulantes possuem uma grande diversidade genética. / The Mamastrovirus 5 (MAstV5) is classified in the genus Mamastrovirus of the Astroviridae family, being associated with acute episodes of transient gastroenteritis in puppies around the world. The aim of this work was to detect and analyze the genetic variability of circulating MAstV5 in dogs in Brazil. For this, rectal swab samples were collected from 269 dogs from different regions of Brazil in the 2008-2014 period, of which 26.39% were positive for MAstV5 by conventional RT-PCR and RT-Hemi-nested PCR, amplifying conserved portion of the capsid gene and polymerase gene, respectively. Four of these strains had its genome sequenced partially characterized and analyzed phylogenetically. The characterization of these samples revealed a remarkable genetic heterogeneity among strains of MAstV5. The low identity between the sequences of capsid gene (<85%) indicate a possible new classification between the two genotypes MAstV5 species. We conclude that the MAstV5 occurs in dogs in Brazil and circulating strains have a high genetic diversity.

O mamastrovirus 5 (MAstV5) é classificado no gênero Mamastrovirus da família Astroviridae, sendo associado com surtos agudos de gastroenterite transitória em filhotes de cães ao redor do mundo. O objetivo desta dissertação foi detectar e analisar a variabilidade genética dos MAstV5 circulantes em cães no Brasil. Para isto, amostras de suabe retal foram coletadas de 269 cães de diferentes regiões do Brasil no período de 2008-2014, dos quais 26,39% foram positivos para MAstV5 através de RT-PCR convencional e de RT-Hemi-nested PCR, amplificando porção conservada do gene do capsídeo e do gene da polimerase, respectivamente. Quatro destas cepas tiveram seu genoma parcialmente sequenciado, caracterizado e analisado filogeneticamente. A caracterização dessas amostras revelou uma notável heterogeneidade genética entre as cepas de MAstV5. A baixa identidade entre as sequências do gene do capsídeo (<85%) indicaria uma possível nova classificação entre a espécie MAstV5 em dois genótipos. Conclue-se que o MAstV5 ocorre em cães no Brasil e as cepas circulantes possuem uma grande diversidade genética. / The Mamastrovirus 5 (MAstV5) is classified in the genus Mamastrovirus of the Astroviridae family, being associated with acute episodes of transient gastroenteritis in puppies around the world. The aim of this work was to detect and analyze the genetic variability of circulating MAstV5 in dogs in Brazil. For this, rectal swab samples were collected from 269 dogs from different regions of Brazil in the 2008-2014 period, of which 26.39% were positive for MAstV5 by conventional RT-PCR and RT-Hemi-nested PCR, amplifying conserved portion of the capsid gene and polymerase gene, respectively. Four of these strains had its genome sequenced partially characterized and analyzed phylogenetically. The characterization of these samples revealed a remarkable genetic heterogeneity among strains of MAstV5. The low identity between the sequences of capsid gene (<85%) indicate a possible new classification between the two genotypes MAstV5 species. We conclude that the MAstV5 occurs in dogs in Brazil and circulating strains have a high genetic diversity.

Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2016-08-25T13:37:26Z No. of bitstreams: 2 Dissertação - Nathânia Dábilla Alves Silva - 2016.pdf: 1926312 bytes, checksum: 08f15d1c8a44d1ed6118f432a6917f2d (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-08-25T13:38:53Z (GMT) No. of bitstreams: 2 Dissertação - Nathânia Dábilla Alves Silva - 2016.pdf: 1926312 bytes, checksum: 08f15d1c8a44d1ed6118f432a6917f2d (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2016-08-25T13:38:53Z (GMT). No. of bitstreams: 2 Dissertação - Nathânia Dábilla Alves Silva - 2016.pdf: 1926312 bytes, checksum: 08f15d1c8a44d1ed6118f432a6917f2d (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2016-04-13 / The norovirus (NoVs) are important viral causative agents of acute gastroenteritis (AGE), affecting individuals of all ages in distinct parts of the word; however, the highest morbi-mortality rates occur mainly in children under five years of age and the elderly. The aim of this study was to to screening NoV by Polymerase Chain Reaction Post Reverse Transcription (RT-qPCR) and real-time (RT-qPCR) in fecal and nasal swab of children up to six years of age, with and without AGE symptoms. Samples were obtained at the Materno Infantil Hospital, from May/2014 to May/2015. Secretor status of children was also determined by enzyme immunoassay and genotyping (FUT2 gene) from the sediment of nasal swab epithelial cells. A global positivity index of 17% (37/219) for NoV in feces, and from these positive children, 48.6% (18/37) had AGE symptoms. Mean viral load in fecal samples was 2.59 x 1010 CG/g from symptomatic and 1.37 x 109 CG/g in asymptomatic. A higher positivity rate (70%) was observed GII NoV, compared to GI NoV (30%) and a higher positivity in children up to 24 month old (67.5%), although not statistically significant. As for the secretor status of children positive for NoV in fecal samples, 94.6% positive secretory status. The NoV were detected in practically every month of the study, and no particular pattern of circulation in relation to dry or rainy seasons was observed. Most children positive for NoV (70%) had the record they have received at least the first dose of the vaccine against Rotavirus, being the highest viral load detected among vaccinated children. The NoV RNA was detected in 8.7% of nasal swab samples of the children and of these, 58% had AGE symptoms. The mean viral load in swab samples from symptomatic children was 2.10 x 108 and in the asymptomatic children was 2.41 x 107 CG/mL. A high NoV genotype variability was found in the study (GI.2, GI.3, GI.5, GII.3, GII.4 and GII.6), with a predominance of GII.4 (28.6%), with this being the first report of NoV GI.5 in Brazil. The data obtained in this study reveal a high frequency, viral load, and genetic variability of NoVs among children attended in a hospital of Goiânia, Goiás. The results are important for a better understanding of NoV epidemiology in nosocomial environment, and may constitute useful information on the advent of the development of an effective vaccine. The viral load in nasal swab samples is a novel data that may contribute for the elucidation of a possible alternative rout of NoV transmission. / Os norovírus (NoVs) são importantes agentes virais causadores de gastroenterite aguda (GEA), atingindo indivíduos de todas as idades em diversas partes do mundo, porém os maiores índices de morbimortalidade ocorrem principalmente nas crianças menores de cinco anos e idosos. O objetivo do presente estudo foi realizar a pesquisa de NoV, através da Reação em Cadeia pela Polimerase Pós-Transcrição Reversa (RT-PCR) e por tempo real (RT-qPCR) em amostras fecais e swab nasal de crianças com até seis anos de idade, com e sem sintomas de GEA. As amostras foram coletadas no Hospital Materno Infantil, entre maio/2014 e maio/2015. Procedeu-se ainda à determinação do status secretor das crianças, por Ensaio Imunoenzimático e genotipagem (gene FUT2), em sedimento de células epiteliais do swab nasal. Foi observado um índice de positividade global de 17% (37/219) para NoV nas fezes, sendo que destas crianças positivas, 48,6% (18/37) apresentavam sintomas de GEA. A carga viral média nas amostras de fezes de crianças com sintomas foi 2,59 x 1010 CG/g e 1,37 x 109 CG/g nas assintomáticas. Observou-se maior positividade para NoV GII (70%) quando comparado ao GI (30%) e maior positividade nas crianças de até 24 meses de idade (67,5%), entretanto este dado não foi estatisticamente significativo. Quanto ao status secretor das crianças positivas para NoV nas fezes, 94,6% status secretor positivo. Os NoV foram detectados em praticamente todos meses do estudo, não sendo observado padrão de circulação definido em relação às estações seca e chuvosa. A maioria das crianças positivas para NoV (70%) tinham o registro de terem recebido pelo menos a primeira dose da vacina contra Rotavírus, sendo a carga viral mais elevada detectada entre crianças vacinadas. O RNA de NoV foi ainda detectado em 8,7% (19/219) das amostras de swab nasal das crianças e destas, 58% apresentavam sintomas de GEA. A carga viral média nas amostras de swab das crianças sintomáticas foi 2,10 x 108 CG/mL e nas assintomáticas 2,41 x 107 CG/mL. Foi observada elevada variabilidade de genótipos de NoV no estudo (GI.2, GI.3, GI.5, GII.3, GII.4 e GII.6), com maior predominância de GII.4 (28,6%), sendo este o primeiro relato de NoV GI.5 no Brasil. Os dados obtidos neste estudo revelam elevada frequência, carga viral e variabilidade genética de NoVs entre crianças atendidas em um hospital de Goiânia, Goiás. Os resultados são importantes para o melhor entendimento da epidemiologia dos NoVs em ambiente nosocomial, e poderão ser uteis como informação no advento do desenvolvimento de uma vacina eficaz. A determinação da carga viral de NoV em xii amostras de swab nasal é um dado novo, podendo este contribuir para a elucidação de uma possível rota alternativa de transmissão dos NoV.